MENU
GPCR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Structure Therapeutics (GPCR) Ownership - Who owns Structure Therapeutics?

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs... Show more

Profile

Industry
N/A
Address
601 Gateway Boulevard
Phone
+1 650 457-1978
Employees
93
Web
https://www.structuretx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.18B
P/E Ratio
N/A
Total Cash
786.5M
Projected Growth
N/A
Total Debt
7.68M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
12.96
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

GPCR
Capitalization
2.18B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
786M
Total Cash/Share
12.96
Total Debt
7.68M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
772M
P/B Ratio
2.83
Cash Flow
N/A
Earnings
-3.15
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
17K
Current Ratio
20.48
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-218.56M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-20.30
Shares Held By Institutions
1.83B
Shares Outstanding - Current
60.7M
Total Liabilities
44.4M
Total Volume MTD
N/A
Value
1
Gain YTD
32.448
View a ticker or compare two or three
GPCR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
601 Gateway Boulevard
Phone
+1 650 457-1978
Employees
93
Web
https://www.structuretx.com